Analysis underscores importance of pretreatment urine cultures in patients with recurrent UTI
Investigators evaluated uropathogen prevalence and antibiotic resistance in a urogynecologic patient population.
In this interview, Megan S. Bradley, MD, discusses findings from the recent Neurourology and Urodynamics paper, Sporadic compared to recurrent urinary tract infections: Considerations for urogynecologic patients, for which she served as a study author. Bradley is an assistant professor in the department of obstetrics, gynecology, and reproductive sciences at the University of Pittsburgh.
More videos:
A primer for urologists on statutes of limitations
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
